PubMed Health⌕ Search

PubMed · 8724262

A parastomal hernia causing small-bowel obstruction.

Abstract

A parastomal hernia is an incisional hernia that occurs at the site of an intestinal stoma on the abdominal wall. We report the case of a 52-year-old woman who had had ulcerative colitis and a total colectomy and ileostomy 9 years before being evaluated for a 2-year history of intermittent small-bowel obstruction thought initially to be due to Crohn's disease. On examination, a clear parastomal hernia was detected and confirmed by a small-bowel series. At surgery the hernia was corrected, and her intermittent episodes of small-bowel obstruction resolved. A parastomal hernia should be considered as a cause of intermittent small-bowel obstruction in anyone who has a stoma. Careful history and physical examination should suffice in establishing a diagnosis.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

D W Markham, M Ruppert, R Noel, C M Surawicz. 1996. A parastomal hernia causing small-bowel obstruction.. https://doi.org/10.1097/00004836-199604000-00014

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

[Prognosis and treatment of chronic inflammatory bowel disease].

BACKGROUND, MATERIAL AND METHODS: Most studies of the prognosis of inflammatory bowel disease have not been population-based; they are retrospective reviews. Moreover, they lack uniform methods for assessment of outcome. The clinical course is difficult to predict and the prognosis has changed over the last decades as a result of progress in medical therapeutics and treatment principles and surgical methods. RESULTS: Patients suffering from Crohn's disease or ulcerative colitis will probably alternate between remission and relapse, with 10% having a relapse-free course after ten years, and only 1% having a continuously active course. There is a cumulative frequency of operation of 50-80% and of reoperation of 1/3 in Crohn's disease. In ulcerative colitis the overall probability of surgery is 1/3 for pancolitis and 10% for proctitis within five years of diagnosis, and the majority of patients are operated on within the first few years. Maintenance treatment with sulphasalazine (SASP) and 5-aminosalicylic acid (5-ASA) in ulcerative colitis has reduced relapse rates to about the half. INTERPRETATION: Changes in disease distribution in ulcerative colitis are part of the natural course of the disease. This should have implications for medical treatment strategies. Inflammatory bowel disease frequently requires potent medication with side-effects that limit patients' acceptance. Certain environmental factors as well as patient compliance are thought to determine the clinical outcome in ulcerative colitis and Crohn's disease.

Colitis, Ulcerative↗